22 Tex. Admin. Code § 170.5 - General Standards for the Use of Investigational Stem Cell Treatments for Patients with Certain Severe Chronic Diseases or Terminal Illnesses
In accordance with Chapter 1003 of the Texas Health and Safety Code, physicians who administer or provide for the use of investigational stem cell treatments must:
(1) comply with all applicable state and
federal laws and rules;
(2) be
certified to administer stem cell in accordance with §
1003.055 of
the Texas Health and Safety Code;
(3) ensure the patient is enrolled in a
clinical trial investigating the use of adult stem cells in humans;
(4) maintain adequate medical records
including documentation of the patient's qualifying severe chronic disease or
terminal illness;
(5) obtain a
signed written informed consent including the patient eligibility determination
found in §1003.053(2)(a) of the Texas Health and Safety Code; and
(6) provide stem cells in a
qualifying facility.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.